OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Pharmacogenetics and Precision Medicine Approaches for the Improvement of COVID-19 Therapies
Mohitosh Biswas, Nares Sawajan, Thanyada Rungrotmongkol, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 22
Mohitosh Biswas, Nares Sawajan, Thanyada Rungrotmongkol, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 22
Showing 22 citing articles:
Small molecule angiotensin converting enzyme inhibitors: A medicinal chemistry perspective
Wenyue Zheng, Erkang Tian, Zhen Liu, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 40
Wenyue Zheng, Erkang Tian, Zhen Liu, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 40
p53/NF-kB Balance in SARS-CoV-2 Infection: From OMICs, Genomics and Pharmacogenomics Insights to Tailored Therapeutic Perspectives (COVIDomics)
Daniela Milani, Lorenzo Caruso, Enrico Zauli, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 27
Daniela Milani, Lorenzo Caruso, Enrico Zauli, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 27
In-silico screening and analysis of missense SNPs in human CYP3A4/5 affecting drug-enzyme interactions of FDA-approved COVID-19 antiviral drugs
Amro A. Abdelazim, Mohamad Maged, Ahmed I. Abdelmaksoud, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
Amro A. Abdelazim, Mohamad Maged, Ahmed I. Abdelmaksoud, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
Pharmacogenomic Study of SARS-CoV-2 Treatments: Identifying Polymorphisms Associated with Treatment Response in COVID-19 Patients
Alex Serra-Llovich, Natàlia Cullell, Olalla Maroñas, et al.
Biomedicines (2025) Vol. 13, Iss. 3, pp. 553-553
Open Access
Alex Serra-Llovich, Natàlia Cullell, Olalla Maroñas, et al.
Biomedicines (2025) Vol. 13, Iss. 3, pp. 553-553
Open Access
Role of Cytochrome P450 2C9 in COVID-19 Treatment: Current Status and Future Directions
Sharoen Yu Ming Lim, Basel Al Bishtawi, Willone Lim
European Journal of Drug Metabolism and Pharmacokinetics (2023) Vol. 48, Iss. 3, pp. 221-240
Open Access | Times Cited: 10
Sharoen Yu Ming Lim, Basel Al Bishtawi, Willone Lim
European Journal of Drug Metabolism and Pharmacokinetics (2023) Vol. 48, Iss. 3, pp. 221-240
Open Access | Times Cited: 10
The Long View on COVID-19 Theranostics and Oral Antivirals: Living with Endemic Disease and Lessons from Molnupiravir
Anmar Al‐Taie, Fatma Rana Denkdemir, Zaineb Sharief, et al.
OMICS A Journal of Integrative Biology (2022) Vol. 26, Iss. 6, pp. 324-328
Closed Access | Times Cited: 13
Anmar Al‐Taie, Fatma Rana Denkdemir, Zaineb Sharief, et al.
OMICS A Journal of Integrative Biology (2022) Vol. 26, Iss. 6, pp. 324-328
Closed Access | Times Cited: 13
Molecular biology of glucose-6-phosphate dehydrogenase and UDP-glucuronosyltransferase 1A1 in the development of neonatal unconjugated hyperbilirubinemia
Yi‐Li Hung, P C Chang, Ching‐Shan Huang
Pediatrics & Neonatology (2024) Vol. 65, Iss. 5, pp. 419-426
Open Access | Times Cited: 2
Yi‐Li Hung, P C Chang, Ching‐Shan Huang
Pediatrics & Neonatology (2024) Vol. 65, Iss. 5, pp. 419-426
Open Access | Times Cited: 2
Solubility determination and thermodynamic model analysis of nevirapine in different organic solvents from 278.15 K to 328.15 K
Rensong Wang, Ningning Sun, Jingjing Yang, et al.
Journal of Molecular Liquids (2022) Vol. 365, pp. 120173-120173
Closed Access | Times Cited: 12
Rensong Wang, Ningning Sun, Jingjing Yang, et al.
Journal of Molecular Liquids (2022) Vol. 365, pp. 120173-120173
Closed Access | Times Cited: 12
Hyperexpression ofPTAFRandPF4as Possible Platelet Risk Biomarkers in Patients With COVID-19
Lívia de Oliveira Sales, Jean Breno Silveira da Silva, Flávia Melo Cunha de Pinho Pessoa, et al.
In Vivo (2024) Vol. 38, Iss. 6, pp. 2853-2863
Open Access | Times Cited: 1
Lívia de Oliveira Sales, Jean Breno Silveira da Silva, Flávia Melo Cunha de Pinho Pessoa, et al.
In Vivo (2024) Vol. 38, Iss. 6, pp. 2853-2863
Open Access | Times Cited: 1
In vitro high-content tissue models to address precision medicine challenges
Samson Afewerki, Thiago Domingues Stocco, André D. R. Silva, et al.
Molecular Aspects of Medicine (2022) Vol. 91, pp. 101108-101108
Open Access | Times Cited: 6
Samson Afewerki, Thiago Domingues Stocco, André D. R. Silva, et al.
Molecular Aspects of Medicine (2022) Vol. 91, pp. 101108-101108
Open Access | Times Cited: 6
Theranostics for COVID-19 Antiviral Drugs: Prospects and Challenges for Worldwide Precision/Personalized Medicine
Caíque Manóchio, Sabrina Torres-Loureiro, Mariana M. Scudeler, et al.
OMICS A Journal of Integrative Biology (2023) Vol. 27, Iss. 1, pp. 6-14
Closed Access | Times Cited: 3
Caíque Manóchio, Sabrina Torres-Loureiro, Mariana M. Scudeler, et al.
OMICS A Journal of Integrative Biology (2023) Vol. 27, Iss. 1, pp. 6-14
Closed Access | Times Cited: 3
Clinical and imaging features of patients with COVID-19 in a double-center cohort study
Mohsen Gholinataj Jelodar, Mahshid Nadershahbaz, Samaneh Mirzaei, et al.
The Journal of Infection in Developing Countries (2024) Vol. 18, Iss. 03, pp. 337-349
Open Access
Mohsen Gholinataj Jelodar, Mahshid Nadershahbaz, Samaneh Mirzaei, et al.
The Journal of Infection in Developing Countries (2024) Vol. 18, Iss. 03, pp. 337-349
Open Access
In-silico analysis of nsSNPs in human CYP3A4/5 and their effects on drug-enzymes interactions of FDA-approved COVID-19 antiviral drugs: A pharmacogenetic study
Amro A. Abdelazim, Mohamad Maged, Ahmed I. Abdelmaksoud, et al.
Research Square (Research Square) (2024)
Open Access
Amro A. Abdelazim, Mohamad Maged, Ahmed I. Abdelmaksoud, et al.
Research Square (Research Square) (2024)
Open Access
The therapeutic landscape for COVID-19 and post-COVID-19 medications from genetic profiling of the Vietnamese population and a predictive model of drug-drug interaction for comorbid COVID-19 patients
Thien Khac Nguyen, Giang Minh Vu, Vinh Chi Duong, et al.
Heliyon (2024) Vol. 10, Iss. 6, pp. e27043-e27043
Open Access
Thien Khac Nguyen, Giang Minh Vu, Vinh Chi Duong, et al.
Heliyon (2024) Vol. 10, Iss. 6, pp. e27043-e27043
Open Access
Constructing a label-free electrochemical biosensor based on magnetic α-Fe2O3/Fe3O4 heterogeneous nanosheets for the sensitive detection of VKORC1*2 gene
Jie Wang, Hezhong Ouyang, Zhihao Xu, et al.
Arabian Journal of Chemistry (2024) Vol. 17, Iss. 8, pp. 105848-105848
Open Access
Jie Wang, Hezhong Ouyang, Zhihao Xu, et al.
Arabian Journal of Chemistry (2024) Vol. 17, Iss. 8, pp. 105848-105848
Open Access
Pharmacogenomics of Chloroquine and Hydroxychloroquine: Current Evidence and Future Implications
Mohitosh Biswas, Chonlaphat Sukasem
Pharmacogenomics (2023) Vol. 24, Iss. 15, pp. 831-840
Closed Access | Times Cited: 1
Mohitosh Biswas, Chonlaphat Sukasem
Pharmacogenomics (2023) Vol. 24, Iss. 15, pp. 831-840
Closed Access | Times Cited: 1
Pharmacogenetic Markers of Favipiravir Safety in COVID-19 Treatment
И. И. Темирбулатов, А. V. Kryukov, К. Б. Мирзаев, et al.
Antibiot Khimioter = Antibiotics and Chemotherapy (2023) Vol. 68, Iss. 5-6, pp. 55-61
Open Access | Times Cited: 1
И. И. Темирбулатов, А. V. Kryukov, К. Б. Мирзаев, et al.
Antibiot Khimioter = Antibiotics and Chemotherapy (2023) Vol. 68, Iss. 5-6, pp. 55-61
Open Access | Times Cited: 1
Pharmacogenomic Landscape of Ivermectin and Selective Antioxidants: Exploring Gene Interplay in the Context of Long COVID
Ying‐Fei Yang, Sher Singh
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 20, pp. 15471-15471
Open Access | Times Cited: 1
Ying‐Fei Yang, Sher Singh
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 20, pp. 15471-15471
Open Access | Times Cited: 1
GDF15 : A modulator of immunity and a predictive biomarker of cardiovascular events : A strategy in COVID-19
Luc Rochette, Geoffrey Dogon, Eve Rigal, et al.
Annales de Cardiologie et d Angéiologie (2022) Vol. 72, Iss. 1, pp. 41-43
Open Access | Times Cited: 2
Luc Rochette, Geoffrey Dogon, Eve Rigal, et al.
Annales de Cardiologie et d Angéiologie (2022) Vol. 72, Iss. 1, pp. 41-43
Open Access | Times Cited: 2
Public Health Issues in Pharmacogenomics
Marius Geantă, Bianca Cucoș, Angela Brand
Springer eBooks (2023), pp. 325-346
Closed Access
Marius Geantă, Bianca Cucoș, Angela Brand
Springer eBooks (2023), pp. 325-346
Closed Access
Disentangling the common genetic architecture and causality of rheumatoid arthritis and systemic lupus erythematosus with COVID-19 outcomes: genome-wide cross trait analysis and bi-directional Mendelian randomization study
Minhao Yao, Xin Huang, Yunshan Guo, et al.
medRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access
Minhao Yao, Xin Huang, Yunshan Guo, et al.
medRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access
Pharmacogenomics at the post-pandemic: If not now, then when?
Zeina N. Al-Mahayri
Frontiers in Pharmacology (2022) Vol. 13
Open Access
Zeina N. Al-Mahayri
Frontiers in Pharmacology (2022) Vol. 13
Open Access
